- Home
- Publications
- Publication Search
- Publication Details
Title
Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options
Authors
Keywords
-
Journal
DRUGS & AGING
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-12
DOI
10.1007/s40266-019-00647-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
- (2019) Pauline T. Lukey et al. EUROPEAN RESPIRATORY JOURNAL
- A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
- (2018) Lyne Gagnon et al. AMERICAN JOURNAL OF PATHOLOGY
- DELPHIning Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis
- (2018) Jeff Swigris AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Combination Therapy and the Start of a New Epoch for Idiopathic Pulmonary Fibrosis?
- (2018) Toby M. Maher AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Treatment of Sarcoidosis
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose-derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
- (2018) Paschalis Ntolios et al. Clinical Respiratory Journal
- Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants
- (2018) Charlotte H. Maden et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Optimising experimental research in respiratory diseases: an ERS statement
- (2018) Philippe Bonniaud et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
- (2018) Toby M Maher et al. Lancet Respiratory Medicine
- Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
- (2018) Scott M. Palmer et al. CHEST
- Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
- (2018) Nasreen Khalil et al. EUROPEAN RESPIRATORY JOURNAL
- Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
- (2017) Alexander V. Misharin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis
- (2017) Sebastian Bickelhaupt et al. JNCI-Journal of the National Cancer Institute
- Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
- (2017) Ana L. Mora et al. NATURE REVIEWS DRUG DISCOVERY
- Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions
- (2017) Jonathan A. Galli et al. RESPIROLOGY
- Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis
- (2017) Sebastian Bickelhaupt et al. JNCI-Journal of the National Cancer Institute
- Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities
- (2016) Jennifer E. Ho et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
- (2016) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
- (2016) Bernt van den Blink et al. EUROPEAN RESPIRATORY JOURNAL
- Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
- (2016) Paul F Mercer et al. THORAX
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease
- (2015) Gauri Saini et al. EUROPEAN RESPIRATORY JOURNAL
- Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
- (2015) John Hutchinson et al. EUROPEAN RESPIRATORY JOURNAL
- Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
- (2015) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis. An Integral Model
- (2014) Moisés Selman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
- (2014) Jacob M. van Laar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis
- (2014) Daniel C. Chambers et al. RESPIROLOGY
- Dysregulation of Galectin-3. Implications for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
- (2013) Andrew R. Cullinane et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
- (2013) Argyris Tzouvelekis et al. Journal of Translational Medicine
- Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2012) Nikos Oikonomou et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Idiopathic Pulmonary Fibrosis: Pathobiology of Novel Approaches to Treatment
- (2011) Toby M. Maher CLINICS IN CHEST MEDICINE
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
- (2010) C. Vancheri et al. EUROPEAN RESPIRATORY JOURNAL
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
- (2010) Lynne A. Murray et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages
- (2010) Lynne A. Murray et al. PLoS One
- Serum Amyloid P Inhibits Fibrosis Through Fc R-Dependent Monocyte-Macrophage Regulation in Vivo
- (2009) A. P. Castano et al. Science Translational Medicine
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
- (2008) Neil C. Henderson et al. AMERICAN JOURNAL OF PATHOLOGY
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started